Total Assets (Quarterly) Chart

View Total Assets (Quarterly) for DCTH.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Assets (Quarterly) Chart
Start Trial

Historical Total Assets (Quarterly) Data

View and export this data back to 2000. Start Trial.
Date Value
June 30, 2026 137.02M
March 31, 2026 124.84M
December 31, 2025 161.99M
September 30, 2025 124.30M
June 30, 2025 116.88M
March 31, 2025 87.32M
December 31, 2024 76.59M
September 30, 2024 31.68M
June 30, 2024 33.91M
March 31, 2024 36.10M
December 31, 2023 38.61M
September 30, 2023 47.58M
June 30, 2023 21.05M
March 31, 2023 30.60M
December 31, 2022 17.86M
September 30, 2022 20.23M
June 30, 2022 21.07M
March 31, 2022 27.32M
December 31, 2021 33.12M
September 30, 2021 34.42M
June 30, 2021 24.92M
March 31, 2021 32.32M
December 31, 2020 34.64M
September 30, 2020 16.56M
June 30, 2020 20.44M
Date Value
March 31, 2020 9.777M
December 31, 2019 14.21M
September 30, 2019 18.90M
June 30, 2019 5.636M
March 31, 2019 6.164M
December 31, 2018 6.844M
September 30, 2018 12.83M
June 30, 2018 5.473M
March 31, 2018 6.418M
December 31, 2017 8.887M
September 30, 2017 14.49M
June 30, 2017 18.60M
March 31, 2017 31.04M
December 31, 2016 35.24M
September 30, 2016 36.98M
June 30, 2016 41.39M
March 31, 2016 12.53M
December 31, 2015 15.73M
September 30, 2015 19.57M
June 30, 2015 17.39M
March 31, 2015 21.65M
December 31, 2014 23.76M
September 30, 2014 26.87M
June 30, 2014 31.33M
March 31, 2014 36.08M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
Abbott Laboratories 109.22B
AngioDynamics, Inc. 267.16M
Alphatec Holdings, Inc. 791.03M
AtriCure, Inc. 676.64M
Baxter International, Inc. 19.79B

Total Assets (Quarterly) Related Metrics